# BPC-157 for GLP-1 Gut Damage

slug: bpc-157-glp1-gut-damage · https://miscsubjects.com/a/bpc-157-glp1-gut-damage · updated 2026-07-17T02:38:35.106Z

## What this covers

GLP-1 agonists like semaglutide and tirzepatide cause gastric emptying delay in 30-40% of users. Nausea, vomiting, and diarrhea are common. Some patients develop gastroparesis-like symptoms.

## What BPC-157 does

BPC-157 accelerates gastric emptying in rodent models. It protects gastric mucosa from NSAID and alcohol damage. It modulates nitric oxide signaling in the gut wall.

## Evidence grade

- BPC-157 gastric emptying: rodent only, moderate quality
- BPC-157 mucosal protection: rodent + limited human case reports, moderate quality
- GLP-1 gut damage mechanism: clinical trial data, high quality

## Practical note

No human trial has tested BPC-157 in GLP-1 users. The mechanistic rationale is strong but unproven clinically.